Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.51
+0.19 (3.01%)
At close: Jul 22, 2025, 4:00 PM
6.47
-0.04 (-0.62%)
After-hours: Jul 22, 2025, 5:12 PM EDT
Bausch Health Companies Stock Forecast
Stock Price Forecast
The 4 analysts that cover Bausch Health Companies stock have a consensus rating of "Hold" and an average price target of $7, which forecasts a 7.53% increase in the stock price over the next year. The lowest target is $3 and the highest is $10.
Price Target: $7 (+7.53%)
Analyst Consensus: Hold
* Price targets were last updated on May 2, 2025.
Analyst Ratings
The average analyst rating for Bausch Health Companies stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $8.5 → $10 | Hold | Maintains | $8.5 → $10 | +53.61% | May 2, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $12 → $8 | Strong Buy → Hold | Downgrades | $12 → $8 | +22.89% | Feb 6, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $11 → $10 | Hold | Maintains | $11 → $10 | +53.61% | Jan 30, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $10 → $11 | Hold | Maintains | $10 → $11 | +68.97% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $10 → $8.5 | Hold | Maintains | $10 → $8.5 | +30.57% | Aug 2, 2024 |
Financial Forecast
Revenue This Year
9.98B
from 9.63B
Increased by 3.71%
Revenue Next Year
10.48B
from 9.98B
Increased by 5.03%
EPS This Year
4.54
from -0.13
EPS Next Year
4.65
from 4.54
Increased by 2.50%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.5B | 11.1B | 11.3B | ||
| Avg | 10.0B | 10.5B | 10.6B | ||
| Low | 9.5B | 10.0B | 10.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.4% | 10.8% | 8.2% | ||
| Avg | 3.7% | 5.0% | 1.0% | ||
| Low | -1.6% | -0.3% | -5.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.95 | 5.30 | 6.26 | ||
| Avg | 4.54 | 4.65 | 5.79 | ||
| Low | 3.98 | 3.72 | 5.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 16.7% | 34.6% | ||
| Avg | - | 2.5% | 24.4% | ||
| Low | - | -18.0% | 15.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.